SCN1A and Dravet syndrome: Particularly for healthcare providers, a deep understanding of these pathogenic genes is useful in properly selecting and adjusting drugs in a more effective and timely manner.<h4>Objective</h4>The purpose of this study was to identify genes other than <i>SCN1A</i> that may also cause DS or DS-like phenotypes.<h4>Methods</h4>A comprehensive search of relevant Dravet syndrome and severe myoclonic epilepsy in infancy was performed in PubMed, until December 1, 2021.